SCHEMBL30358422

SCHEMBL30358422

CCCC1CC(CC2CC(CCC)C(N)C(CCC)C2)CC(CCC)C1N

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ NOS1 P29475 2/20 0.32
▸ NOS2 P35228 2/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA4 P22748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20816024 0.86 CYP1A2 (0.37) NOS1NOS2
SCHEMBL20816017 0.85 ALOX5 (0.39) NOS1NOS2
SCHEMBL20816015 0.83 ALOX5 (0.42) —
SCHEMBL464976 0.80 — —
SCHEMBL21359774 0.76 NOS1 (0.33) NOS1NOS2
SCHEMBL30358406 0.76 — —
SCHEMBL30358475 0.76 — —
SCHEMBL8850800 0.76 NOS1 (0.33) NOS1NOS2CA1CA2CA4
SCHEMBL20816002 0.76 CYP1A2 (0.32) NOS1NOS2
SCHEMBL30358419 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630661-B2 Additives useful in 3D printing technologies Evonik Operations GmbII (DE) 2026-05-19 — — US claimed
CN-115960328-A Additives for 3D printing techniques 赢创运营有限公司 2023-04-14 — — CN claimed
CN-115960328-A Additives for 3D printing techniques 赢创运营有限公司 2023-04-14 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630661-B2 Additives useful in 3D printing technologies HTR3D, HTR3B, HTR3C NOS1 705/4885NOS2 535/4885CA1 4649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback